Indivior PLC is a global pharmaceutical company engaged in developing medicines to treat substance-use disorders (SUD). The Company provides treatment for addiction, including SUBLOCADE (buprenorphine extended-release) injection for subcutaneous use, a long-acting injectable (LAI) for opioid use disorder and OPVEE (Nalmefene) nasal spray for opioid overdose recovery. Its core products include SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, OPVEE (nalmefene), and SUBLOCADE. SUBOXONE Film is a buprenorphine and naloxone sublingual film. SUBOXONE Tablet is a buprenorphine and naloxone sublingual tablet. SUBUTEX Tablet is a buprenorphine sublingual tablet. SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, and SUBLOCADE are treatments for opioid use disorder (OUD). In addition to its commercially available products, its product pipeline includes two drug candidates for the treatment of OUD. The Company sells its products in the United States and in other selected areas of the world.
Código da empresaINDV
Nome da EmpresaIndivior PLC
Data de listagemDec 24, 2014
CEOCiaffoni (Joseph J)
Número de funcionários1030
Tipo de títulosOrdinary Share
Fim do ano fiscalDec 24
Endereço234 Bath Road
CidadeSLOUGH
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited Kingdom
Código postalSL1 4EE
Telefone448043791090
Sitehttps://www.indivior.com/en
Código da empresaINDV
Data de listagemDec 24, 2014
CEOCiaffoni (Joseph J)
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.

Sem dados